← Back to Search

Behavioral Intervention

Positive Airway Pressure Therapy for Sleep Apnea

N/A
Recruiting
Research Sponsored by NovaResp Technologies Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must have a new diagnosis of moderate or severe OSA (AHI > 15 events/hour)
Must be 18-70 years old
Must not have
Subjects actively using bi-level PAP or require oxygen therapy
Neuromuscular disease, hypoglossal-nerve palsy, severe restrictive or obstructive pulmonary disease, moderate-to-severe pulmonary arterial hypertension, severe valvular heart disease, New York Heart Association class III or IV heart failure, recent myocardial infarction or severe cardiac arrhythmias (within the past 6 months), persistent uncontrolled hypertension despite medication use, active psychiatric disease, and coexisting non-respiratory sleep disorders that would confound functional sleep assessment
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to compare how well patients with newly diagnosed obstructive sleep apnea stick to their Positive Airway Pressure therapy. It will look at whether proactive therapy or conventional Automatic-PAP therapy is better

Who is the study for?
This trial is for adults aged 18-70 who have just been diagnosed with moderate or severe Obstructive Sleep Apnea (OSA), meaning they have more than 15 breathing interruptions per hour of sleep. Participants should be able to follow the study's procedures and understand English. Those with uncontrolled, severe heart or brain conditions cannot join.
What is being tested?
The study compares two treatments for OSA: Proactive CPAP Therapy and standard Automatic-PAP (APAP) Therapy. It looks at how well patients stick to these therapies over short-term (3 months) and long-term periods (12 months), as well as their health outcomes like airway blockage during sleep, nightly use, mask fit, and patient feedback.
What are the potential side effects?
While not specified here, common side effects of PAP therapy can include discomfort from the mask or straps, dry nose or throat, nasal congestion, runny nose, irritation on the skin where the mask sits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been newly diagnosed with moderate or severe sleep apnea.
Select...
I am between 18 and 70 years old.
Select...
I don't have severe heart or brain problems that aren't under control.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I use a bi-level PAP machine or need oxygen therapy.
Select...
I do not have severe heart, lung, muscle, nerve conditions, uncontrolled high blood pressure, recent heart attack, severe sleep disorders or active psychiatric disease.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adherence
Secondary study objectives
Apnea-Hypopnea Index
CPAP Therapy Usage
Self-assessed functional outcomes
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Proactive CPAP Therapy (Intervention)Experimental Treatment1 Intervention
Patients will undergo CPAP enabled with proactive therapy.
Group II: Conventional APAP Therapy (Control)Active Control1 Intervention
Patients will undergo conventional APAP therapy.

Find a Location

Who is running the clinical trial?

NovaResp Technologies IncLead Sponsor
3 Previous Clinical Trials
75 Total Patients Enrolled
~100 spots leftby Jun 2025